| Q92968397 | A nomogram prediction model for recurrent laryngeal nerve lymph node metastasis in thoracic oesophageal squamous cell carcinoma |
| Q53159547 | Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case. |
| Q90331199 | Cervical or thoracic anastomosis for patients with cervicothoracic esophageal squamous cell carcinoma |
| Q64081270 | Clinical manifestation, risk factors and managements for postoperative chylothorax after thoracic esophagectomy |
| Q34013220 | Clinicopathologic characteristics of esophagectomy for esophageal carcinoma in elderly patients |
| Q40229704 | Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression. |
| Q58798284 | Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis |
| Q79633215 | Comparison of the outcomes between open and minimally invasive esophagectomy |
| Q89754191 | Continuous intraoperative vagus nerve stimulation for monitoring of recurrent laryngeal nerve during minimally invasive esophagectomy |
| Q30240008 | Current Status and Future Prospects for Esophageal Cancer Treatment |
| Q34100102 | Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence |
| Q36936943 | Determining the optimal number of lymph nodes harvested during esophagectomy |
| Q34750782 | Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma |
| Q38644635 | Efficacy and Safety of Endoscopic Resection Followed by Chemoradiotherapy for Superficial Esophageal Squamous Cell Carcinoma: A Retrospective Study. |
| Q64923179 | Efficacy and predictor of octreotide treatment for postoperative chylothorax after thoracic esophagectomy. |
| Q60044800 | Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach |
| Q38671121 | Esophageal Cancer: Current Options for Therapeutic Management |
| Q33398141 | Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry |
| Q41429352 | Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas |
| Q86532369 | Extended lymphadenectomy in esophageal cancer is debatable |
| Q42632837 | Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center |
| Q37344265 | Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus |
| Q34658684 | Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View |
| Q38093060 | Lymph node dissection for esophageal cancer |
| Q26769064 | Lymphatic spreading and lymphadenectomy for esophageal carcinoma |
| Q36418207 | Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome |
| Q37560738 | Middle and lower esophagectomy preceded by hand-assisted laparoscopic transhiatal approach for distal esophageal cancer |
| Q89796210 | Minimally invasive esophagectomy via Sweet approach in combination with cervical mediastinoscopy for esophageal squamous cell carcinoma: a case series |
| Q38067386 | Multidisciplinary approach for patients with esophageal cancer |
| Q38072285 | Oesophageal cancer--an overview |
| Q43251193 | Patterns and Prognostic Significance of Cervical Lymph Node Metastasis and the Efficacy of Cervical Node Dissection in Esophageal Cancer |
| Q54484856 | Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma. |
| Q84608851 | Postoperative Radiotherapy Improved Survival of Poor Prognostic Squamous Cell Carcinoma Esophagus |
| Q55527127 | Predictive factors for major postoperative complications related to gastric conduit reconstruction in thoracoscopic esophagectomy for esophageal cancer: a case control study. |
| Q34552165 | Preventing and localizing esophagogastric anastomosis leakage by sleeve-wrapping of the pedicled omentum |
| Q82295989 | Prevention of postoperative chylothorax with thoracic duct ligation during video-assisted thoracoscopic esophagectomy for cancer |
| Q82837247 | Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma |
| Q58801063 | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
| Q91876392 | Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma |
| Q41225314 | Risk Factors and Clinical Outcomes of Recurrent Laryngeal Nerve Paralysis After Esophagectomy for Thoracic Esophageal Carcinoma |
| Q83468757 | Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta |
| Q42180630 | Risk factors for postoperative respiratory complications following esophageal cancer resection |
| Q47967657 | Robotic-assisted minimally invasive esophagectomy for treatment of esophageal carcinoma. |
| Q79889179 | Solitary nodal recurrence in the dorsal area of the thoracic aorta after a curative resection of esophageal cancer: report of two cases |
| Q64069445 | Successful multidisciplinary treatment including repeated metastasectomy for recurrent squamous cell esophageal carcinoma: a case report |
| Q81477961 | Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy |
| Q36531698 | Surgical treatment of superficial esophageal cancer |
| Q83753075 | The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? |
| Q35048093 | The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. |
| Q41202637 | Three-field lymph node dissection in esophageal cancer surgery |
| Q28077519 | Three-field lymph node dissection in treating the esophageal cancer |
| Q43409892 | Tracheobronchial lesions following esophagectomy: erosions, ulcers, and fistulae, and the predictive value of lymph node-related factors |
| Q45175358 | Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection |
| Q42380323 | Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer |